PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer.
Saved in:
| Title: | PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer. |
|---|---|
| Authors: | Long LL; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China., Ma SC; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.; Information Management and Big Data Center, Nanfang Hospital, Southern Medical University, Guangzhou, China., Guo ZQ; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China., Zhang YP; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.; Information Management and Big Data Center, Nanfang Hospital, Southern Medical University, Guangzhou, China., Fan Z; Institute of Life and Health Engineering, Jinan University, Guangzhou, China., Liu LJ; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Southern Medical University, and Guangdong Provincial Key Laboratory of Single Cell Technology and Application, Guangzhou, China., Liu L; Information Management and Big Data Center, Nanfang Hospital, Southern Medical University, Guangzhou, China.; Department of Medical Quality Management, Nanfang Hospital, Southern Medical University, Guangzhou, China., Han DD; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China., Leng MX; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China., Wang J; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China., Guo XJ; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China., Tan JL; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China., Cai XT; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China., Lin Y; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China., Pan X; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Southern Medical University, and Guangdong Provincial Key Laboratory of Single Cell Technology and Application, Guangzhou, China., Wu DH; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China., Bai X; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China., Dong ZY; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China. |
| Source: | Cancer research [Cancer Res] 2023 Feb 15; Vol. 83 (4), pp. 568-581. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
